EL.En. (ELN) Q1 2026 earnings summary

Executive summary

• Consolidated revenues reached €145.6 million in Q1 2026, up 3.3% year-over-year, with double-digit earnings growth and strong cash generation.

• EBITDA rose 9% to €23.7 million, and EBIT increased 14% to €19.9 million, with EBIT margin improving to 13.6% from 12.4%.

• The medical sector drove all revenue and profitability growth, while the industrial sector experienced a temporary contraction.

• European markets led revenue growth, up 17% year-over-year, while the Italian market declined in both main sectors.

Financial highlights

• Gross margin improved to €67.2 million (46.1% of revenue), up 7% from €62.9 million (44.7%) in Q1 2025.

• EBITDA margin increased to 16.3% from 15.4% year-over-year.

• Net financial position was cash positive at €173.7 million, up from €172.2 million at year-end 2025.

• Pre-tax income rose to €20 million, up 22.6% from €16.3 million in Q1 2025.

Outlook and guidance

• 2026 guidance confirmed: management expects around 5% revenue growth and further EBIT margin improvement despite global uncertainties.

• Order backlog and demand trends support a positive outlook for the year.